Bugworks Research Announces the First in Human Phase 1 Study o...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Nov. 8, 2021 /PRNewswire-Asianet/ -- Bugworks research today announced that the first human dose was administered in a Phase 1 clinical trial evaluating BWC0977: a next generation broad-spectrum, novel bacterial topoisomerase inhibitor (NBTI), supported by Combating Antibiotic-Re...
Authors: LATEST ASIANET NEWS RELEASES